Clinical Trials Sponsored by Hillhurst Biopharmaceuticals, Inc.
Total 116 results
-
Hillhurst Biopharmaceuticals, Inc.National Heart, Lung, and Blood Institute (NHLBI)CompletedAnemia, Sickle CellUnited States
-
Hillhurst Biopharmaceuticals, Inc.National Heart, Lung, and Blood Institute (NHLBI)Not yet recruiting
-
NGM Biopharmaceuticals, IncCompletedImpaired Hepatic FunctionUnited States
-
NGM Biopharmaceuticals, IncCompleted
-
Alder Biopharmaceuticals, Inc.CompletedMigraine DisorderUnited States
-
NGM Biopharmaceuticals, IncCompleted
-
NGM Biopharmaceuticals, IncCompleted
-
RegeneRx Biopharmaceuticals, Inc.WithdrawnMyocardial Infarction | Myocardial IschemiaUnited States
-
AgoneX Biopharmaceuticals, Inc.Not yet recruiting
-
NGM Biopharmaceuticals, IncCompletedNonalcoholic Steatohepatitis | Compensated CirrhosisUnited States, Australia, Belgium, France, Germany, Hong Kong, Poland, Puerto Rico, United Kingdom
-
NGM Biopharmaceuticals, IncActive, not recruitingMelanoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Non-small Cell Lung Cancer | Metastatic Castration-resistant Prostate Cancer | Head Neck Squamous Cell CarcinomaUnited States
-
NGM Biopharmaceuticals, IncTerminated
-
NGM Biopharmaceuticals, IncCompletedHealthy MaleUnited States
-
NGM Biopharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Alder Biopharmaceuticals, Inc.CompletedMigraine DisordersUnited States, Belgium, Italy, Spain, United Kingdom, Germany, Hungary, Georgia, Slovakia, Russian Federation, Ukraine, Denmark, Czechia
-
Alder Biopharmaceuticals, Inc.CompletedMigraine DisordersUnited States, Georgia, Australia, New Zealand
-
NGM Biopharmaceuticals, IncCompletedPrimary Sclerosing CholangitisUnited States, France, Netherlands, United Kingdom
-
NGM Biopharmaceuticals, IncCompletedFunctional ConstipationUnited States
-
RegeneRx Biopharmaceuticals, Inc.Terminated
-
Alder Biopharmaceuticals, Inc.Completed
-
Gracell Biopharmaceuticals, Inc.RecruitingRelapsed/ Refractory Multiple MyelomaUnited States
-
NGM Biopharmaceuticals, IncCompletedGeographic AtrophyUnited States
-
RegeneRx Biopharmaceuticals, Inc.WithdrawnST Elevation Myocardial Infarction | Acute Myocardial Infarction | STEMI
-
NGM Biopharmaceuticals, IncCompleted
-
Alder Biopharmaceuticals, Inc.CompletedMigraine DisordersUnited States, Georgia
-
NGM Biopharmaceuticals, IncCompletedImpaired Renal FunctionUnited States
-
Alder Biopharmaceuticals, Inc.Completed
-
NGM Biopharmaceuticals, IncCompleted
-
RegeneRx Biopharmaceuticals, Inc.Completed
-
Paradigm Biopharmaceuticals USA (INC)Active, not recruitingOsteoarthritis, KneeAustralia, United States
-
Paradigm Biopharmaceuticals USA (INC)Active, not recruitingOsteoarthritis, KneeUnited States, Australia
-
Asklepios Biopharmaceutical, Inc.RecruitingCardiovascular Diseases | Heart Failure | Heart Failure, Diastolic | Congestive Heart Failure | Heart Failure, Systolic | Heart Disease, Ischemic | Heart Failure，Congestive | Heart Arrhythmia | Heart; ComplicationsUnited States
-
Asklepios Biopharmaceutical, Inc.RecruitingParkinson's Disease | Multiple System Atrophy | Multiple System Atrophy, Parkinson VariantUnited States, Poland
-
Asklepios Biopharmaceutical, Inc.RecruitingCongestive Heart FailureUnited States
-
Asklepios Biopharmaceutical, Inc.RecruitingMuscular Dystrophy | Limb Girdle Muscular Dystrophy | LGMD2I | LGMD | Limb-Girdle Muscular Dystrophy Type 2 | LGMD2 | FKRP | FKRP Mutation | Fukutin Related ProteinUnited States
-
Asklepios Biopharmaceutical, Inc.Active, not recruiting
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.RecruitingStudy of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's LymphomaCD20-positive B-cell Non-Hodgkin's LymphomaChina
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.RecruitingAdvanced Breast Cancer | Advanced Solid Tumor | Advanced Gastric CancerUnited States
-
Zhejiang Clover Biopharmaceuticals, Inc.Active, not recruiting
-
Ethicon, Inc.OMRIX BiopharmaceuticalsCompleted
-
Ethicon, Inc.OMRIX BiopharmaceuticalsCompletedDura DefectsBelgium, Finland, France, Germany, Netherlands, United Kingdom
-
Ethicon, Inc.OMRIX BiopharmaceuticalsCompletedCardiovascular, Neurologic (Spine), and General SurgeryUnited States
-
NGM Biopharmaceuticals, IncNGM Biopharmaceuticals Australia Pty LtdCompleted
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.RecruitingSolid Tumor | Classic Hodgkin LymphomaChina
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Not yet recruitingB-cell Non-Hodgkin's Lymphoma
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Not yet recruiting
-
Sichuan Clover Biopharmaceuticals, Inc.RecruitingChemotherapy-induced Thrombocytopenia (CIT)China
-
Day One Biopharmaceuticals, Inc.RecruitingMelanoma | Colorectal Cancer | Solid Tumor | Non Small Cell Lung Cancer | Bladder Cancer | Thyroid Cancer, Papillary | Pilocytic Astrocytoma | Bladder Urothelial Carcinoma | Non-Small Cell Adenocarcinoma | MEK Mutation | RAS Mutation | Pancreatic Acinar Carcinoma | RAF Mutation | CRAF Gene Amplification | RAF1 Gene Amplification and other conditionsUnited States, Canada, Korea, Republic of, Spain, Australia, Belgium, France
-
Sichuan Clover Biopharmaceuticals, Inc.Completed